10,000 Agilent Technologies, Inc. $A Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS cut its position in Agilent Technologies, Inc. (NYSE:A) by 62.2% during the third quarter, HoldingsChannel reports. The firm owned 6,075 shares of the medical research company’s stock after selling 10,000 shares during the quarter. Kornitzer Capital Management Inc. KS’s holdings in Agilent Technologies were worth $1,047,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. State Street Corp grew its position in shares of Agilent Technologies by 0.7% in the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock valued at $1,710,658,000 after buying an additional 89,598 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of Agilent Technologies by 2.7% during the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock worth $990,206,000 after buying an additional 198,253 shares during the last quarter. Deutsche Bank AG increased its position in Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares during the period. Bank of New York Mellon Corp increased its position in Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after acquiring an additional 2,440,360 shares during the period. Finally, Legal & General Group Plc purchased a new stake in Agilent Technologies during the 2nd quarter valued at approximately $260,101,000.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. The Goldman Sachs Group increased their price target on Agilent Technologies from $175.00 to $185.00 and gave the stock a “buy” rating in a report on Monday, September 21st. Robert W. Baird lifted their price objective on shares of Agilent Technologies from $180.00 to $195.00 and gave the company an “outperform” rating in a research report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Agilent Technologies in a research note on Monday, October 26th. They issued a “buy” rating and a $190.00 price objective on the stock. Finally, Royal Bank Of Canada boosted their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Eighteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $181.45.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Stock Performance

NYSE A opened at $180.09 on Tuesday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $182.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The business has a 50 day moving average price of $166.45 and a 200 day moving average price of $137.40. The company has a market capitalization of $50.77 billion, a P/E ratio of 35.45, a PEG ratio of 2.59 and a beta of 1.24.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter in the previous year, the business posted $1.37 earnings per share. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were paid a $0.2550 dividend. The ex-dividend date of this dividend was Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s payout ratio is presently 20.08%.

Agilent Technologies Company Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.